Editorial
doi: 10.1001/jama.299.15.1833.
Impugning the integrity of medical science: the adverse effects of industry influence
- PMID: 18413880
- DOI: 10.1001/jama.299.15.1833
Item in Clipboard
Editorial
Impugning the integrity of medical science: the adverse effects of industry influence
JAMA.
.
No abstract available
Comment in
-
How to ensure our readers' trust: the proper attribution of authors and contributors.Am J Ophthalmol. 2008 Sep;146(3):337-40. doi: 10.1016/j.ajo.2008.06.007. Am J Ophthalmol. 2008. PMID: 18724976 No abstract available.
-
Guest authorship, mortality reporting, and integrity in rofecoxib studies.JAMA. 2008 Aug 27;300(8):900; author reply 904-6. doi: 10.1001/jama.300.8.900-a. JAMA. 2008. PMID: 18728255 No abstract available.
-
Guest authorship, mortality reporting, and integrity in rofecoxib studies.JAMA. 2008 Aug 27;300(8):901-2; author reply 904-6. doi: 10.1001/jama.300.8.901-c. JAMA. 2008. PMID: 18728256 No abstract available.
-
Guest authorship, mortality reporting, and integrity in rofecoxib studies.JAMA. 2008 Aug 27;300(8):902; author reply 904-6. doi: 10.1001/jama.300.8.902-a. JAMA. 2008. PMID: 18728260 No abstract available.
-
Guest authorship, mortality reporting, and integrity in rofecoxib studies.JAMA. 2008 Aug 27;300(8):903-4; author reply 905-6. doi: 10.1001/jama.300.8.903-b. JAMA. 2008. PMID: 18728261 No abstract available.
-
Guest authorship, mortality reporting, and integrity in rofecoxib studies.JAMA. 2008 Aug 27;300(8):903; author reply 905-6. doi: 10.1001/jama.300.8.903-a. JAMA. 2008. PMID: 18728262 No abstract available.
-
Guest authorship, mortality reporting, and integrity in rofecoxib studies.JAMA. 2008 Aug 27;300(8):904; author reply 905-6. doi: 10.1001/jama.300.8.904-a. JAMA. 2008. PMID: 18728263 No abstract available.
Comment on
-
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.JAMA. 2008 Apr 16;299(15):1800-12. doi: 10.1001/jama.299.15.1800. JAMA. 2008. PMID: 18413874
-
Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation.JAMA. 2008 Apr 16;299(15):1813-7. doi: 10.1001/jama.299.15.1813. JAMA. 2008. PMID: 18413875
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
